Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement
June 03, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, June 03, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics developer, today announced the official opening of BioNua Limited, its...
Nexvet Provides Update on Upcoming Investor Symposium at Irish Biomanufacturing Facility
May 27, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 27, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is pleased to provide an update on its Investor Symposium, which...
Nexvet Announces Positive Results from NV-02 Pilot Field Study in Cats with Osteoarthritis
May 26, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 26, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced statistically significant efficacy results from its...
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016
May 12, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 12, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and nine-month periods ended...
Nexvet to Host Symposium at American College of Veterinary Internal Medicine (ACVIM) Forum to Present Additional NV-01 Pivotal Data in Canine Pain and Clinical Data for NV-02 in Feline Pain
May 11, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 11, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced it will host a symposium to present expanded pivotal safety and...
Nexvet to Host Investor Symposium at its Irish Biomanufacturing Facility
May 04, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 04, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the hosting of an Investor Symposium on June 3, 2016 at BioNua,...
Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer
May 02, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 02, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, and Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.), a leading Japanese animal health...
Nexvet Announces Successful Completion of NV-01 Pilot Field Study in Dogs With Osteoarthritis
March 08, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, March 08, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the successful completion of its pilot field study for...
Nexvet to Present at the Cowen and Company 36th Annual Health Care Conference
February 29, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced that its Chief Executive Officer, Dr. Mark Heffernan, is...
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2016
February 16, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and six month periods ended...